Skip to main content
Premium Trial:

Request an Annual Quote

It's in the Fine Print

The success of companies such as 23andMe and Navigenics hinges on good data security, says Blaine Bettinger at the Genetic Genealogist. "A single security breach could potentially drive away future customers," he blogs. Bettinger also points to Ryan Calo's discussion of a panel at Stanford. Calo says that Navigenics "has committed in writing to resisting court orders, subpoenas, and other requests for information about their customers" and that 23andMe has made a similar promise, though verbally.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.